This review covers recent literature on the lamellarins, a family of marine natural products, and related analogs, encompassing synthetic strategies for total synthesis, structure-activity relationships (SAR), and studies on mechanisms of biological action, namely in the context of antitumor activity. It reviews work published
Introduction
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Lamellarin D (Lam-D, Fig. 1 ), which comes from a large family of marine pyrrole alkaloids, is currently in preclinical development as an anti-cancer drug. Comprehensive reviews of this compound were published in 2007 and 2008. Lam-D exerts its anti-tumor activity through complementary pathways: a nuclear route via topoisomerase I (Topo I) 25 inhibition, 5, 6 and mitochondrial targeting by induction of mitochondrial permeability transition (MPT). 7 Robust synthesis of Lam-D has enabled SAR and mechanism of action studies. Thus, the vast chemical space of the Lam structure has been explored through modified 30 analogs, including 1-dearyl, 8 2-dearyl, 9 lactone-free derivatives, 10 lactam, 11 and polymeric and peptidic nuclear location signal conjugates. 12, 13 Herein, in addition to the recent synthetic strategies developed for total synthesis of Lam-D and its numerous 35 naturally occurring and synthetic analogs, recent work on SAR studies and on using multi-target mechanisms to induce apoptosis are also discussed. 40 Numerous synthetic strategies based on the formation of the five-membered pyrrole heterocycle have been developed for the pentacyclic core of the Lamellarins (Fig. 2) . 14 This procedure has not yet been exploited in natural product synthesis. 50 The key step in a recent synthesis of Lam-G trimethyl ether 15 is the final step: haloarylation of 3-bromo-4-(3,4-dimethoxybenzoyl)-6,7-dimethoxy-chroman-2-one 3 with 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (Scheme 1).
Synthesis of Lamellarins
1.a. Construction of the pyrrole core
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Scheme 1 Key step in the synthesis of Lam-G trimethyl ether 15 1-Benzyl-3,4-dihydroisoquinolines have been transformed to Lam-G trimethyl ether and Lam-U using short reaction sequences. Grob reaction of dihydroisoquinoline 4 with the nitrocinnamate 5 afforded pyrroles 6a and 6b. 16 Gupton et al. 17 reported formal syntheses of Lam-G trimethyl ether and ningalin B via formation of the 10 polysubstituted pyrrole derivatives 7a and 7b, respectively, from a vinylogous iminium salt derivative. Subsequent transformations of these highly substituted pyrroles enabled efficient regio-controlled formal syntheses of the targets (Scheme 3). 
1.b. Cross-coupling reactions
Efforts towards Lamellarin synthesis have vastly benefited 30 from Pd(0) catalyzed cross-coupling chemistry-namely, the Heck, Negishi and Suzuki reactions. Recently reported methodologies for these compounds using this chemistry are described below. A general method for the synthesis of N-unsubstituted 3,4-diarylpyrrole-2,5-dicarboxylates also has been developed.
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The principal reactions comprised a Hinsberg-type synthesis of dimethyl N-benzyl-3,4-dihydroxypyrrole-2,5-dicarboxylate 15 followed by palladium-catalyzed Suzuki-Miyaura coupling of its bis-triflate derivative. The N-benzyl protecting group of the resulting 3,4-diarylpyrrole-2,5-dicarboxylates was cleanly removed under hydrogenolysis or solvolysis. The authors observed that the regioselectivity of the Suzuki cross-coupling 20 of dihalopyrrole esters was influenced by the reaction solvent. 8 using a methodology that they had previously developed. In the synthesis of the dendrimeric-and NLS-Lam-D bioconjugates 20 and 21, the amino and guanidino groups of the oligomeric building blocks were protected with N-Boc. 
Molecular Structure-Activity Determinants, and SAR Studies
Natural products remain an underutilized source of leads for the pharmaceutical industry. 26 Preparing analogs of these 35 products through medicinal chemistry approaches to explore maximum chemical space is a valuable method for improving and/or modulating the parent biological activity. Given their diverse anti-tumor activities, lamellarins have been the subject of several SAR studies in recent years. between Lam-D and combretastatin A4, which contains a conserved cis-stilbene motif. They evaluated twenty-two 5 novel, diversely-substituted analogs, which they then screened for anti-proliferative activities against five cancer cell lines. The compounds generally showed poor activity (submillimolar IC 50 values); the most active of them are shown in Fig. 3 Nevertheless, we believe these results reflect a partial but promising structural simplification. Selective removal of the 20 O-iPr groups would easily afford the corresponding free phenolic groups at positions C8 and C4', which are crucial for the activity of open-chain methyl ester lamellarin analogs. 9 The Hu group's results are in agreement with previous findings related to the presence of the OH at C4" of the aryl at 25 position 2 of the pyrrolo[2,1-a]isoquinoline, which are also crucial role for activity. Ruchirawat et al. extensively assessed the cytotoxic activities of 25 lamellarins against multiple cancer cell lines derived from six different cancer types (oral, lung, breast, liver, cervix, and blood cell). 27 The compounds comprised 22 naturally occurring lamellarins and three synthetic derivatives 5 containing either a saturated or an unsaturated C8-C9 bond, and bearing different OMe, OH and H substitution patterns on the aryl rings. Their SAR studies were the first to reveal the importance of having an OH group at C10 for biological activity and also confirmed prior findings 1,2 that the C8=C9 10 double bond increases cytotoxicity; that the OH groups at C3 and C11 are crucial to activity; and that methylation of the OH groups at C12, C3' and C4' induces only subtle changes in the GI 50 values. 27 Lamellarins-D, -X, -ε, -M, -N, and dehydro-Lam-J were the 15 most potent anti-tumor compounds of the family (Fig. 4) : they had IC 50 values ranging from sub-nanomolar (0.08 nM) to micromolar (3.2 µM). 27 Furthermore, they showed selectivity against cancer cells: these lamellarins were roughly 3 to 1,000,000 times more toxic to cancer cells from all eleven cell 20 lines tested than to the control (normal) cells, MRC-5 human embryonic lung fibroblasts (Table 2) . 27 In related work, Lam-D and its bioconjugates were similarly selective for cancer cells over BJ skin fibroblasts.
12, 13
Hannongbua et al. have studied lamellarins using receptor-25 independent (RI) 4D quantitative SAR (QSAR) models.
28, 29
They obtained valuable 3D pharmacophore information from a set of 25 structurally complex lamellarins screened in silico against human hormone dependent T47D breast cancer cells. Overall, they identified formation of an intermolecular 30 hydrogen bond, and the hydrophobic interactions of substituents at C10, C11 and C12, as the most important features for cytotoxicity against the cancer cells. 12 For example, the monoPEG 15a is up to 80-times more soluble in water than Lam-D. Moreover, a release of up to 97% of Lam-D has been achieved by incubation of 15a for 6 h at 37 °C in Dubelcco's modified Eagle's medium 10 (DMEM) supplemented with 10% fetal bovine serum (FBS), and 100 units/mL penicillin and streptomycin. 13 The cytotoxicity of the bioconjugates 15, 16, 18, 20 and 21 was assessed against three human tumor cell lines (MDA-MB-231 breast, A-549 lung and HT-29 colon). Several compounds 15 exhibited greater cellular internalization than did Lam-D, and more than 85% of the bioconjugates showed a lower GI 50 than did Lam-D.
12,13 Cellular internalization was analyzed, and a nuclear distribution pattern was observed for bioconjugate 21, which contains an NLS. 13 The mechanisms of action for D and these derivatives have been indentified as cell cycle arrest at G2 phase and apoptotic cell-death pathways.
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In summary, the various SAR studies and virtual screening models for lamellarins and related analogs discussed above have demonstrated the efficacy of targeted medicinal 25 chemistry. The findings from this work may contribute to future drug development of synthetic analogs and to the selection of synthetic scaffolds.
Activities and Mechanism of Action of Lam-D Topo I is a nuclear target of Lam-D
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Inhibition of the nuclear DNA relaxation enzyme Topoisomerase I (Topo I) by Lam-D has recently been characterized in a model system of highly nicked doublestranded DNA (dsDNA) by using optical tweezers forcestretching experiments (Fig. 5a ). In these experiments, normal 35 Topo I activity-which ultimately leads to total repair of the DNA nicks-is shown by a higher force plateau in DNA stretching-relaxation plots and complete disappearance of the overstretching hysteresis (Figs. 5b and 5c, green curves) . When Lam-D is added to the system, it prevents the religation 40 step and blocks enzyme turnover, as seen by the absence of a higher force plateau and by a large, non-vanishing hysteresis between the stretching and relaxing paths of the force cycle ( Figure 5d , green curve). Inhibition of Topo I by Lam-D has also been demonstrated by atomic force microscopy (AFM) imaging of plectonemic DNA molecules with Topo I enzyme attachments that were treated with a combination of Lam-D and a reaction buffer used to relax supercoiled DNA (see Fig. 6 ). In 2010 the same research group ultimately identified direct induction of mitochondrial permeability transition (MPT), which leads to swelling and cytochrome c release, as the mechanism behind the pro-apoptotic function of Lam-D. 
Inhibition of protein kinases
Maijer et al. have also identified a new molecular target of lamellarins. 4 They reported that lamellarins inhibit several protein kinases relevant to cancer, including cyclin-dependent 95 kinases, dual specificity tyrosine phosphorylation activated kinase 1A, casein kinase 1, glycogen synthase kinase-3 and PIM-1. They found a good correlation between inhibition of protein kinases by lamellarins and cell death. This suggests that specific kinases may contribute to these drugs' 100 cytotoxicity, and could be harnessed together with the drugs' other bioactivities to achieve anti-tumor effects. Further studies in this area are needed.
Conclusions and Future Trends
The unique structures and biological activities of the 105 lamellarins and related pyrrole-derived alkaloids have attracted significant synthetic efforts in recent years. Thus, elegant synthetic routes to these compounds or their key intermediates have been developed. Since 2008, Lam-G trimethyl ether has been synthesized using four novel 110 strategies, in total yields ranging from 5% to 45% [15] [16] [17] 24 These highly modular approaches can provide access to any member of the family; one need only choose the appropriately substituted and protected building blocks. Additionally, these chemistries have proven valuable for preparation of structurally simplified lamellarin analogs, affording sufficient 5 quantities for SAR and other biological studies.
The initial SAR studies on lamellarins have provided the first evidence that an OH group at C10 position is important for biological activity. 27 Latter work demonstrated the importance of the C8=C9 double bond, and confirmed the importance of the OH groups at C3 and C11. To date, Lam-D, X, ε, M and N, and dehydro-Lam-J are the most potent antitumor compounds of this family.
Further SAR studies of the 1-dearyl Lam-D analogs synthesized by Iwao et al. 8 could provide useful data and a 15 more thorough overview on structural simplification of the parent compound. Incorporation of polar groups onto the core to facilitate further H-bonding interactions, as well as ionizable groups to enhance the solubility, can yield improved lamellarin analogs. Further studies can contribute to a better understanding of the mechanism of lamellarins and their analogs, and will be beneficial for the ongoing pharmacological optimization of this class of compounds.
